Post-IPO Equity - Benitec Ltd
Investment Firm
Overview
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
Announced Date
Apr 18, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
3
Round Details and Background
Benitec Ltd raised $40000000 on 2024-04-18 in Post-IPO Equity
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 11, 2023 |  Post-IPO Equity - Benitec Ltd | 3 | - | 3.0M |
| Apr 18, 2024 | Post-IPO Equity - Benitec Ltd | 3 | - | 40.0M |
| Mar 13, 2017 | Post-IPO Equity - Benitec Ltd | 1 | - | 4.1M |
| Apr 15, 2014 | Post-IPO Equity - Benitec Ltd | - | 29.5M |
Recent Activity
There is no recent news or activity for this profile.